Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: A fluorescence in situ hybridization study and correlation with histologic features

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 3, 2005, Pages 143-151

  Mazzucchelli, Roberta ^a   Barbisan, Francesca ^a   Stramazzotti, Daniela ^a   Montironi, Rodolfo ^a   Lopez Beltran, Antonio ^b   Scarpelli, Marina ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Universidad de Cordoba   (Spain)

Author keywords

Bladder cancer; Chromosomal aberrations; Hybridization, fluorescence in situ; Urothelium

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CELL NUCLEUS; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; UROGENITAL TRACT TUMOR; UROTHELIUM;

AGED; CARCINOMA IN SITU; CARCINOMA, PAPILLARY; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 22144448941     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (editors): Tumours of the urinary system. In WHO Classification of tumours: Tumours of the Urinary System and Male Genital Organs. Lyon, IARC Press, 2004, pp 90-123
2. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG: Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer. 2000;88:1663-1670
3. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL: Stage progression in Ta papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor, markers, mitotic frequency and DNA ploidy. J Urol 2001;165:1124-1128
4. Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI: Papillary urothelial hyperplasia: A precursor to papillary neoplasms. Am J Surg Pathol. 1996;20:1481-1488
5. Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F, Heim S: Cytogenetic monoclonality in multifocal uroepithelial carcinomas: Evidence of intraluminal tumour seeding. Br J Cancer 1999;81:6-12
6. Simon R, Eltze E, Schafer KL, Burger H, Semjonow A, Hertle L, Dockhorn-Dworniczak B, Terpe HJ, Bocker W: Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 2001;61:355-362
7. Murphy WM, Busch C, Algaba F: Intraepithelial lesions of urinary bladder: Morphologic considerations. Scand J Urol Nephrol (suppl) 2000;205:67-81
8. Brandau S, Bohle A: Bladder cancer: I. Molecular and genetic basis of carcinogenesis. Eur Urol 2001;39:491-497
9. Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S, Benedict WF: Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 2000;27:392-402
10. Knowles MA: Molecular genetics of bladder cancer. Br J Urol 1995;75:57-66
11. Edwards J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JMS: Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder. J Pathol 2002;196:380-385
12. Sobin LH, Wittekind CH: IUCC/TNM: Classification of Malignant Tumours. Sixth edition. New York, Wiley & Sons, 2002
13. Baithun SI, Naase M, Blanes A, Diaz-Cano SJ: Molecular and kinetic features of transitional cell carcinomas of the bladder: Biological and clinical implications. Virchows Arch 2001;438: 289-297
14. Catto JWF, Meuth M, Hamdy FC: Genetic instability and transitional cell carcinoma of the bladder. Br J Urol Int 2004; 93:19-24
15. Cairns P, Shaw ME, Knowles MA: Initiation of bladder cancer may involve deletion of tumour-suppressor gene on chromosome 9. Oncogene 1993;8:1083-1085
16. Stadler WM, Steinberg G, Yang X, Hagos F, Turner C, Olopade OI: Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin Cancer Res 2001;7:1676-1682
17. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G: Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 1999;59:4658-4661
18. Placer J, Espinet B, Salido M, Solé F, Gelabert-Mas A: Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: A FISH study. Urology 2005;65:913-918
19. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch MJ, Gasser TC, Sauter G: Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 1999;59:5687-5691
20. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ: Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998; 185:345-351
21. Cianciulli AM, Bovani R, Leonardo C, Iori F, Coletta AM, Marzano R, Antenucci A, Gandolfo GM, Laurenti C: DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: Prognostic implications. Eur J Histochem 2001;48:65-71
22. Ribal NJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofré C, Palou J, Gelabert A, Villavicencio H: Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of bladder. Eur Urol 2004;45:593-599
23. Li M, Zhang ZF, Reuter VE, Cordon-Cardo C: Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol 1996;149: 229-235
24. Watters AD, Ballantyne SA, Going JJ, Grigor KM, Bartlett JMS: Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. Br J Urol 2000;85:42-47
25. Gallucci M, Guadagni F, Leonardo C, Merola R, Sentinelli S, Ruggeri EM, Cantiani R, Sperduti I, Lopez F de L, Cianciulli AM: Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: Correlation with adjacent mucosa and pathological parameters. J Clin Pathol 2005;58:367-371
26. Wagner U, Budendorf L, Gasser TC, Moch H, Gorog JP, Richter J, Mihatsch MJ, Waldman FM, Sauter G: Chromosome 8p delations are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol 1997;151:753-759
27. Chatterjee SJ, Datar R, Youssefzadeh D, George B, Goebell PJ, Stein JP, Young L, Shi SR, Gee C, Groshen S, Skinner DG, Cote RJ: Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 2004;22:1007-1013
28. Baud E, Catilina P, Boiteux JP, Bignon YJ: Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion. Int J Cancer 1998;77:821-824
29. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R: Frequent genetic alteration in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154:721-727
30. Junker K, Kania K, Fiedler W, Hartmann A, Schubert J, Werner W: Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. Int J Oncol 2002;20:647-653
31. Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A: Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH and FISH analyses. J Pathol 2003;199:50-57
32. Steidl C, Simon R, Burger H, Brinkschmidt C, Hertle L, Bocker W, Terpe HJ: Patterns of chromosomal aberrations in urinary bladder tumors and adjacent urothelium. J Pathol 2002;198:115-120